Skip to main content

Chronic Ischemic Mitral Regurgitation

Abstract

Ischemic mitral regurgitation (MR) is mitral regurgitation due to complications of coronary artery disease, in particular myocardial infarction (MI), and not the fortuitous association of coronary artery disease with intrinsic valve disease such as degenerative, myxomatous, and connective tissue valvular disease, spontaneous ruptured chordae tendinae, and other causes of acute or chronic MR due to infection, inflammation, trauma, congenital abnormalities (including mitral valve (MV) prolapse), annular calcification, or tumor. Accordingly, the term ischemic MR should be restricted to chronic MR, occurring more than 2 weeks after MI and in the absence of structural MV disease. From a pathogenic point of view, it is a manifestation of postinfarction ventricular remodeling. The size, location, and transmurality of the MI sets in motion left ventricle (LV) remodeling that determines the severity, time course, and clinical manifestation of ischemic MR. The presentation develops insidiously over time in association with congestive heart failure.

Keywords

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Maisel AS, Gilpin EA, Klein L, Le Winter M, Henning H, Collins D. The murmur of papillary muscle dysfunction in acute myocardial infarction; clinical features and prognostic implications. Am Heart J. 1986;112:705-711.

    Article  CAS  PubMed  Google Scholar 

  2. Barzilai B, Gessler C Jr, Pérez JE, Schaab C, Jaffe AS. Significance of Doppler-detected mitral regurgitation in acute myocardial infarction. Am J Cardiol. 1988;61:220-223.

    Article  CAS  PubMed  Google Scholar 

  3. Lehmann KG, Francis CK, Dodge HT. Mitral regurgitation in early myocardial infarction: incidence, clinical detection, and prognostic implications: TIMI Study Group. Ann Intern Med. 1992;117:10-17.

    CAS  PubMed  Google Scholar 

  4. Loperfido Loperfido F, Biasucci LM, Pennestri F, et al. Pulsed Doppler echocardiographic analysis of mitral regurgitation after myocardial infarction. Am J Cardiol. 1986;58:692-697.

    Article  Google Scholar 

  5. Tcheng JE, Jackman JD Jr, Nelson CL, et al. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med. 1992;117:18-24.

    CAS  PubMed  Google Scholar 

  6. Hickey MS, Smith LR, Muhlbaier LH, et al. Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation. 1989;798:I51-I59.

    Google Scholar 

  7. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik J. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759-1764.

    CAS  PubMed  Google Scholar 

  8. He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation. 1997;96:1826-1834.

    CAS  PubMed  Google Scholar 

  9. Roberts WC, Cohen LS. Left ventricular papillary muscles. Description of the normal and a survey of conditions causing them to be abnormal. Circulation. 1972;46:138-154.

    CAS  PubMed  Google Scholar 

  10. Sharma SK, Seckler J, Israel DH, Borrico S, Ambrose JA. Clinical, angiographic and anatomic findings in acute severe ischemic mitral regurgitation. Am J Cardiol. 1992;70:277-280.

    Article  CAS  PubMed  Google Scholar 

  11. Hendren WG, Nemec JJ, Lytle BW, et al. Mitral valve repair for ischemic mitral insufficiency. Ann Thorac Surg. 1991;52:1246-1251.

    Article  CAS  PubMed  Google Scholar 

  12. Rankin JS, Feneley MP, Hickey MS, et al. A clinical comparison of mitral valve repair versus valve replacement in ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 1988;95:165-177.

    CAS  PubMed  Google Scholar 

  13. Kaul S, Spotnitz WD, Glasheen WP, Touchstone DA. Mechanism of ischemic mitral regurgitation. An experimental evaluation. Circulation. 1991;84:2167-2180.

    CAS  PubMed  Google Scholar 

  14. Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation. 2005;112:745-758.

    Article  PubMed  Google Scholar 

  15. Tenenbaum A, Leor J, Motro M, et al. Improved posterobasal segment function after thrombolysis is associated with decreased incidence of significant mitral regurgitation in a first inferior myocardial infarction. J Am Coll Cardiol. 1995;25:1558-1563.

    Article  CAS  PubMed  Google Scholar 

  16. Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation. 2001;104:I68-I75.

    Article  CAS  PubMed  Google Scholar 

  17. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol. 2003;41:765-770.

    Article  PubMed  Google Scholar 

  18. Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Sade LE, Gorscan J 3rd. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol. 2004;44:1619-1625.

    Article  PubMed  Google Scholar 

  19. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol. 1996;28:1083-1091.

    Article  CAS  PubMed  Google Scholar 

  20. Heinle SK, Tice FD, Kisslo J. Effect of dobutamine stress echocardiography on mitral regurgitation. J Am Coll Cardiol. 1994;25:122-127.

    Article  Google Scholar 

  21. Kizilbash AM, Willett DL, Brickner ME, Heinle SK, Grayburn PA. Effects of afterload reduction on vena contracta width in mitral regurgitation. J Am Coll Cardiol. 1998;32:427-431.

    Article  CAS  PubMed  Google Scholar 

  22. Godley RW, Wann LS, Rogers EW, Feigenbaum H, Weyman AE. Incomplete mitral leaflet closure in patients with papillary muscle dysfunction. Circulation. 1981;63:565-571.

    CAS  PubMed  Google Scholar 

  23. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction. A quantitative clinical study. Circulation. 2000;102:1400-1406.

    CAS  PubMed  Google Scholar 

  24. Agricola E, Oppizzi M, Maisano F, et al. Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern. Eur J Echocardiogr. 2004;5:326-334.

    Article  PubMed  Google Scholar 

  25. Agricola E, Oppizzi M, Pisani M, Meris A, Maisano F, Margonato A. Ischemic mitral regurgitation: mechanisms and echocardiographic classification. Eur J Echocardiogr. 2007;9:207-221.

    Google Scholar 

  26. Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Circulation. 2001;104:1958-1963.

    Article  CAS  PubMed  Google Scholar 

  27. Salgo IS, Gorman JH 3rd, Gorman RC, et al. Effect of annular shape on leaflet curvature in reducing mitral leaflet stress. Circulation. 2002;106:711-717.

    Article  PubMed  Google Scholar 

  28. Watanabe N, Ogasawara Y, Yamaura Y, et al. Mitral annulus flattens in ischemic mitral regurgitation: geometric differences between inferior and anterior myocardial infarction: a realtime 3-dimensional echocardiographic study. Circulation. 2005;112:I458-I1462.

    Article  PubMed  Google Scholar 

  29. Ahmad RM, Gillinov AM, McCarthy PM, Blackstone EH, et al. Annular geometry and motion in human ischemic mitral regurgitation: novel assessment with three-dimensional echocardiography and computer reconstruction. Ann Thorac Surg. 2004;78:2063-2068.

    Article  PubMed  Google Scholar 

  30. De Simone R, Wolf I, Mottl-Link S, et al. A clinical study of annular geometry and dynamics in patients with ischemic mitral regurgitation: new insights into asymmetrical ring annuloplasty. Eur J Cardiothorac Surg. 2006;29:355-361.

    Article  PubMed  Google Scholar 

  31. Otsuji Y, Kumanohoso T, Yoshifuku S, et al. Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy. J Am Coll Cardiol. 2002;39:1651-1656.

    Article  PubMed  Google Scholar 

  32. He S, Lemmon JD Jr, Weston MW, Jensen MO, Levine RA, Yoganathan AP. Mitral valve compensation for annular dilatation: in vitro study into the mechanisms of functional mitral regurgitation with an adjustable annulus model. J Heart Valve Dis. 1999;8:294-302.

    CAS  PubMed  Google Scholar 

  33. Lapu-Bula R, Robert A, Vancrayenest D, et al. Contribution of exercise-induced mitral regurgitation to exercise stroke volume and exercise capacity in patients with dilated cardiomyopathy. Circulation. 2002;106:1342-1348.

    Article  PubMed  Google Scholar 

  34. Lancellotti P, Lebrun F, Pierard LA. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2003;42:1921-1928.

    Article  PubMed  Google Scholar 

  35. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777-802.

    Article  PubMed  Google Scholar 

  36. Matsumura Y, Fukuda S, Tran H, et al. Geometry of the proximal isovelocity surface area in mitral regurgitation by 3-dimensional color Doppler echocardiography: difference between functional mitral regurgitation and prolapse regurgitation. Am Heart J. 2008;155:231-238.

    Article  PubMed  Google Scholar 

  37. Matsumura Y, Saracino G, Sugioka K, et al. Determination of regurgitant orifice area with the use of a new three-dimensional flow convergence geometric assumption in functional mitral regurgitation. J Am Soc Echocardiogr. 2008;21:1251-1256.

    Article  PubMed  Google Scholar 

  38. Schwammenthal E, Chen C, Benning F, Block M, Breithardt G, Levine RA. Dynamics of mitral regurgitant flow and orifice area. Physiologic application of the proximal flow convergence method: clinical data and experimental testing. Circulation. 1994;90:307-322.

    CAS  PubMed  Google Scholar 

  39. Buck T, Plicht B, Kahlert P, Schenk IM, Hunold P, Erbel R. Effect of dynamic flow rate and orifice area on mitral regurgitant stroke volume quantification using the proximal isovelocity surface area method. J Am Coll Cardiol. 2008;52: 767-778.

    Article  PubMed  Google Scholar 

  40. Magne J, Pibarot P, Dagenais F, Hachicha Z, Dumesnil JG, Sénéchal M. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation. 2007;115: 782-791.

    Article  PubMed  Google Scholar 

  41. Watanabe N, Ogasawara Y, Yamaura Y, et al. Quantitation of mitral valve tenting in ischemic mitral regurgitation by transthoracic real-time three-dimensional echocardiography. J Am Coll Cardiol. 2005;45:763-769.

    Article  PubMed  Google Scholar 

  42. Lancellotti P, Troisfontaines P, Toussaint AC, Pierard LA. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation. 2003;108:1713-1717.

    Article  PubMed  Google Scholar 

  43. Vanoverschelde J-L, Pasquet A, Gerber BL, Melin LA. Principles of myocardial viability. Implications for echocardiography. In: Kisslo J, Nihoyannopoulos P, eds. Echocardiography. London: Springer; 2009:351-365.

    Google Scholar 

  44. de Waroux JB Le Polain, Pouleur AC, Vancraeynest D, et al. Early hazards of mitral ring annuloplasty in patients with moderate to severe ischemic mitral regurgitation undergoing coronary revascularization: the importance of preoperative myocardial viability. J Heart Valve Dis. 2009;18:35-43.

    Google Scholar 

  45. Penicka M, Linkova H, Lang O, et al. Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery. Circulation. 2009;120:1474-1481.

    Article  PubMed  Google Scholar 

  46. Flynn M, Curtin R, Nowicki ER, et al. Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: A pilot cardiovascular magnetic resonance imaging study. J Thorac Cardiovasc Surg. 2009;137: 1063-1070.

    Article  PubMed  Google Scholar 

  47. Stevenson LW, Bellil D, Grover-McKay M, et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1987;60:654-658.

    Article  CAS  PubMed  Google Scholar 

  48. Levine AB, Muller C, Levine TB. Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling. Am J Cardiol. 1998;82:1299-1301.

    Article  CAS  PubMed  Google Scholar 

  49. Bonet S, Agusti A, Arnau JM, et al. Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients’ characteristics: a meta-analysis of clinical trials. Arch Intern Med. 2000;160: 621-627.

    Article  CAS  PubMed  Google Scholar 

  50. Lowes BD, Gill EA, Abraham WT, et al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol. 1999;83: 1201-1205.

    Article  CAS  PubMed  Google Scholar 

  51. Capomolla S, Febo O, Gnemmi M, et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J. 2000;139:596-608.

    Article  CAS  PubMed  Google Scholar 

  52. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 1998;115:381-386.

    Article  CAS  PubMed  Google Scholar 

  53. Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation. 2004;110:II103-II108.

    PubMed  Google Scholar 

  54. Braun J, Bax JJ, Versteegh MI, et al. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur J Cardiothorac Surg. 2005;27:847-853.

    Article  PubMed  Google Scholar 

  55. Hung J, Papakostas L, Tahta SA, et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation. 2004;110:II85-II90.

    Article  PubMed  Google Scholar 

  56. Ereminiene E, Vaskelyte J, Benetis R, Stoskute N. Ischemic mitral valve repair: predictive significance of restrictive left ventricular diastolic filling. Echocardiography. 2005;22: 217-224.

    Article  PubMed  Google Scholar 

  57. Kongsaerepong V, Shiota M, Gillinov AM, et al. Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. Am J Cardiol. 2006;98:504-508.

    Article  PubMed  Google Scholar 

  58. De Bonis M, Lapenna E, La Canna G, et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the “edge-to-edge” technique. Circulation. 2005;112:I402-I408.

    PubMed  Google Scholar 

  59. Akins CW, Hilgenberg AD, Buckley MJ, et al. Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation. Ann Thorac Surg. 1994;58: 668-675.

    Article  CAS  PubMed  Google Scholar 

  60. Gillinov AM, Wierup PN, Blackstone EH, et al. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg. 2001;122:1125-1141.

    Article  CAS  PubMed  Google Scholar 

  61. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Louis Vanoverschelde .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London Limited

About this chapter

Cite this chapter

Vanoverschelde, JL., El Khoury, G., Pasquet, A. (2010). Chronic Ischemic Mitral Regurgitation. In: Bonser, R., Pagano, D., Haverich, A. (eds) Mitral Valve Surgery. Springer, London. https://doi.org/10.1007/978-1-84996-426-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-84996-426-5_4

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84996-425-8

  • Online ISBN: 978-1-84996-426-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics